Latest Content

Grounded in Nature: Finding Strength While Living with Lynch Syndrome

July 22nd 2025, 5:00pm

By Georgia Hurst

Article

Living with Lynch syndrome, nature’s quiet resilience teaches me to accept change, find calm, and stay rooted through life’s unexpected twists and storms.

Clinical Trial Confirms Keytruda and Lenvima Benefit in Kidney Cancer

July 22nd 2025, 4:00pm

By Russ Conroy

Article

Data from the KEYNOTE-B61 trial show tumor shrinkage in different types of kidney cancer, including papillary and chromophobe subtypes.

Can Tagrisso Plus Chemo Help Patients With Lung Cancer Live Longer?

July 22nd 2025, 3:00pm

By Spencer Feldman

Article

Tagrisso with chemo significantly improved survival and progression-free outcomes versus Tagrisso alone in newly diagnosed advanced EGFR-mutated lung cancer.

Addressing Cancer Care Barriers with Compassion and Cost Savings

July 22nd 2025, 1:19pm

By Kasey Bowden

Video

Disparities in cancer care can often lead to delays, disruptions, and barriers to timely treatment, leading to an unmet need in the community treatment space.

Should I Quit My Day Job While Living With Cancer?

July 21st 2025, 9:00pm

By Laura Yeager

Article

Keeping my part-time teaching job during breast cancer treatment gave me purpose, connection and strength — and it helped me rediscover my voice as a writer.

How Q-TWiST Can Guide Kidney Cancer Treatment Choices

July 21st 2025, 8:00pm

By Dr. Thomas Powles

Video

Q-TWiST may help patients with advanced kidney cancer and their doctors weigh treatment options by focusing on quality of life, not just disease control.

Metastasis-Directed Radiotherapy Shows Improved Kidney Cancer Outcomes

July 21st 2025, 7:00pm

By Tim Cortese

Article

Stereotactic body radiotherapy costs less and has shown better safety compared with immunotherapy and tyrosine kinase inhibitors in patients kidney cancer.

Zusduri Shows Durable Responses in Some Bladder Cancers

July 21st 2025, 6:00pm

By Spencer Feldman

Article

Treatment with Zusduri had a median duration of response of 3.5 years and event-free survival of two years in low-grade intermediate-risk bladder cancer.

IV Complications and the Challenge of Being Heard

July 21st 2025, 5:00pm

By Martha Carlson

Article

IV infiltration and extravasation remind this cancer patient of the constant challenges of speaking up and advocating for their own care.

Save Meds, Save Lives: How to Donate Your Extra Cancer Medication

July 21st 2025, 4:00pm

By Dr. George Wang

Article

Billions of dollars of cancer meds go to waste each year while many patients struggle to afford treatment; donating surplus medicine helps bridge this gap.

Kidney Cancer Research Embraces Biology-Driven Precision Approach

July 21st 2025, 1:00pm

By Dr. Ari Hakimi

Video

Dr. Ari Hakimi highlighted how tumor profiling and molecular markers are expanding access to precision-based trials for kidney cancer.

Welireg Improves Quality-Adjusted Survival Time in Advanced RCC

July 20th 2025, 6:00pm

By Russ Conroy

Article

Welireg improved quality-adjusted survival time versus Afinitor in advanced renal cell carcinoma, extending progression-free survival and reducing side effects.

Dual-Targeting CAR T Therapy Shows Potential in Advanced Kidney Cancer

July 20th 2025, 2:00pm

By Ashley Chan

Article

Researchers are building on the success of CAR T therapy in blood cancers to explore its use in clear cell renal cell carcinoma, a type of kidney cancer.

Personalized Neoantigen Vaccines Show Lasting Tumor Control in Kidney Cancer

July 19th 2025, 6:00pm

By Ashling Wahner

Article

Early data suggest personalized neoantigen vaccines activate the immune system and sustain tumor control in some patients with kidney cancer.

High-Fiber Diet Linked to Better Treatment Responses in Skin Cancer

July 19th 2025, 2:00pm

By Ryan Scott

Article

Patients with skin cancer who were fed a high-fiber diet showed better response rates to treatment and longer event-free survival, according to data from the DIET trial.